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Objectives The purpose of this study was to evaluate the prognostic value of coronary artery calcium (CAC), a known
marker of subclinical atherosclerosis, in a large, ethnically diverse cohort of 14,812 patients for the prediction of
all-cause mortality.
Background Disparities in case fatality rates for heart disease among ethnic groups are well known. In 2001, rates of death
from heart disease were 30% higher among African Americans (AA) than non-Hispanic whites (NHW). Some of
this variability may be due to differing pathophysiological mechanisms and effects of underlying atherosclerosis.
Methods Ten-year death rates from all causes (total deaths 505) were compared using risk-adjusted Cox proportional haz-
ards models in AA (n  637), Hispanic (HS, n  1,334), Asian (AS, n  1,065), and NHW (n  11,776) populations.
Results Ethnic minority patients were generally younger (0.3 to 4 years), more often persons with diabetes (p 
0.0001), hypertensive (p  0.0001), and female (p  0.0001). The prevalence of CAC scores 100 was highest
in NHW (31%) and lowest for HS (18%) (p  0.0001). Overall survival was 96%, 93%, and 92% for AS, NHW,
and HS, respectively, as compared with 83% for AA (p  0.0001). When comparing prognosis by CAC scores in
ethnic minorities as compared with NHW, relative risk ratios were highest for AA with CAC scores 400 exceed-
ing 16.1 (p  0.0001). Hispanics with CAC scores 400 had relative risk ratios from 7.9 to 9.0, whereas AS
with CAC scores 1,000 had relative risk ratios 6.6-fold higher than NHW (p  0.0001).
Conclusions Consistent with population evidence, AA with increasing burden of subclinical coronary artery disease were
the highest-risk ethnic minority population. These data support a growing body of evidence noting substan-
tial differences in cardiovascular risk by ethnicity. (J Am Coll Cardiol 2007;50:953–60) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.066a
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ithnic diversity in the U.S. is rapidly increasing, and
nformation about differing cardiovascular disease (CVD)
isk among different subgroups is sparse (1). Cardiovascular
isease is still the leading cause of death in the U.S. (2).
See page 961
owever, CVD-associated morbidity and mortality varies
idely across different ethnic groups, and these differences
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alifornia; §Department of Imaging and Medicine, Cedars-Sinai Medical Center,
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opkins University, School of Medicine, Baltimore, Maryland. Dr. Nasir is sup-
orted by grant no. 1T32 HL076136-02 from the National Institutes of Health,
ethesda, Maryland. Dr. Budoff is on the Speakers’ Bureau of GE Healthcare. See
ccompanying online Cardiosource Slide Set.r
Manuscript received January 23, 2007; revised manuscript received March 8, 2007,
ccepted March 12, 2007.re likely influenced by genetic and environmental factors as
ell as lifestyle (3). Moreover, the patterns of CVD may
ave evolved in these ethnic groups over time, complicating
he simultaneous interpretation of current and earlier studies
4). The Cardiovascular Science and Health Care Dispari-
ies Minority Health Summit in 2003 encouraged addi-
ional research on ethnic disparities in CVD risk factors,
utcomes, health care use, and effective risk factor modifi-
ation as well as recommended increased minority partici-
ation in scientific studies (1).
Some of this ethnic variability may be due to differing
athophysiological mechanisms and effects of underlying
therosclerosis, which is the main cause of CVD mortal-
ty (5). A direct relationship has been established between
oronary artery calcium (CAC) scores and atherosclerotic
urden as well as future CVD events in asymptomatic
ndividuals (6 –11). Recent studies suggest that CAC
iffers among ethnic groups (12–16). Despite an ever-
ncreasingly ethnically diverse U.S. population, our cur-
ent understanding of the predictive accuracy of CAC in ethnic
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Ethnic Differences in Prognosis of CAC September 4, 2007:953–60minorities is lacking. The purpose
of the current report was to eval-
uate the differential prognostic
value of the extent and severity of
CAC determined by electron
beam tomography (EBT) in pre-
dicting all-cause mortality in an
ethnically diverse asymptomatic
population.
Methods
Study population. The study
sample consisted of 14,812 asymp-
tomatic subjects, including 637
African Americans (AA), 1,065
Asians (AS), 1,334 Hispanics
(HS), and 11,776 non-Hispanic
hites (NHW), referred by their primary care physicians
etween 1991 and 2004 for CAC screening with EBT.
mong the Asians we excluded the 248 younger, Asian Indian
atients where only 2 deaths were observed.
Individuals were referred for screening on the basis of the
resence of established risk factors and, as such, were not an
nselected cohort representative of the general population.
atients with a history of coronary disease (i.e., a history
hat included admission to the hospital for chest pain, acute
oronary syndrome, or myocardial infarction, as well as prior
oronary angiography and revascularization) were excluded.
All screened individuals provided informed consent to
ndergo EBT screening, and our study received the Human
nvestigations Committee approval. Furthermore, separate
pproval from the Human Investigations Committee was
btained, along with informed consent, for the patient
nterviews, collection of data and follow-up, and corrobo-
ation of the occurrence of death.
isk factor data collection. Risk factor data were derived
hrough patient interview, referring physician contact, and
xisting medical record data. Hypertension was defined as a
ocumented history of high blood pressure or treatment
ith medication, diet, and/or exercise. A history of coronary
isease in a first-degree relative was considered premature if
eported in a male relative 55 years and in female relatives
65 years. A history of current smoking or cessation of
moking within 3 months before testing was defined as
ositive smoking status. A high cholesterol level was defined
s reported hypercholesteromia and/or use of cholesterol-
owering medicine. Individuals were classified as having
iabetes mellitus if they had received a previous diagnosis of
iabetes mellitus that was determined with blood glucose
evels or if they had received treatment with insulin or oral
ypoglycemic agents.
BT. Electron beam tomography was performed with
ither a C-100 or C-150 scanner (Imatron, South San
rancisco, California), and images were obtained with
Abbreviations
and Acronyms
AA  African American(s)
AS  Asian(s)
CAC  coronary artery
calcium
CI  confidence interval
CVD  cardiovascular
disease
EBT  electron beam
tomography
HS  Hispanic(s)
NHW  non-Hispanic
white(s)
RR  relative risk00-ms scanning time. The computed tomography section phickness was 3 mm, and, in total, 40 sections were obtained
tarting at the level of the carina and proceeding to the
evel of the diaphragm. Computed tomography was
lectrocardiographically triggered at 60% to 80% of the
-R interval. Coronary artery calcium was defined as a
laque of at least 3 contiguous pixels (area  1.03 mm2)
ith attenuation of 130 HU or greater. Quantitative
AC scores were calculated according to the method
escribed by Agatston et al. (17).
ollow-up data collection. Epidemiologic methods for
ollow-up included ascertainment of events by individuals
linded to historical and CAC results. The occurrence of
ll-cause death was verified with the National Death Index.
ndividuals who underwent cardiovascular screening were
ollowed up for a mean of 6.8  0.02 years (standard error
f the mean), with a range of 0.7 to 14.5 years.
tatistical methods. Death from all causes was the primary
nd point for this registry. For comparisons between ethnic
roups, categorical risk factors and CAC score subsets were
ompared using chi-square statistic. A logistic regression
odel was used to compare the likelihood of CAC across
thnic subsets. Time to death from all causes was estimated
sing a Cox proportional hazards model. For the Cox
odel, univariable and multivariable models were developed
nd included an evaluation of traditional cardiac risk factors
nd CAC score measurements in all ethnic groups. Specif-
cally, risk-adjusted or multivariable prognostic models were
mployed to assess the independent prognostic value of
AC in ethnic groups while controlling for other cardiac
isk factors including age, hypertension, hyperlipidemia,
iabetes, and a family history of premature coronary artery
isease. From the Cox models, relative risk (RR) ratios and
5% confidence intervals (CIs) were calculated. Relative risk
atios (95% CI) for calcium subsets of 11 to 100, 101 to 400,
01 to 99, and 1,000, respectively, were calculated for all
thnic subgroups.
Because the primary aim of the study was to assess
hether the association of increasing levels of CAC differed
cross ethnic groups, a first-order test for interaction of
thnicity by CAC score was also entered into a Cox
egression model. Furthermore, a stratified Cox survival
nalysis plotted survival by CAC subsets from 0 to 10, 11 to
00, 101 to 400, 401 to 999, and 1,000, respectively, for
ll ethnic groups. Survival rates were rounded to the nearest
enth of a percent.
We previously reported methods for the estimation of
atient life expectancy based upon observed age at the time
f testing (18,19). Based upon observed age at EBT
maging, expected life expectancy was assigned based upon
ational normative statistics for age and gender subsets from
he Centers for Disease Control. A patient’s life expectancy
as assigned as their time to death from nonsurvivors.
ormative life expectancy estimates were further revised
ased upon a multivariable model including age, CAC
cores, and other cardiac risk factors resulting in a calculated
redicted survival function. From this model, a total life
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September 4, 2007:953–60 Ethnic Differences in Prognosis of CACxpectancy estimate was derived as a product of predicted
urvival function by the normative life expectancy estimate.
ll life expectancy estimates were stratified by ethnicity,
ge, and CAC score subsets of 100, 400, and 1,000,
espectively. Life expectancy estimates for these latter sub-
ets were compared using nonparametric statistics including
independent samples using the Kruskal-Wallis statistic.
esults
ardiac risk factor and CAC prevalence rates. Coronary
eart disease risk factor data across the ethnic groups are
hown in Table 1. African American subjects had a signif-
cantly higher prevalence of diabetes mellitus (p 0.01) and
ore frequent history of hypertension (p  0.03) compared
ith NHW. However, NHW subjects were significantly
lder (p  0.0001) with a greater prevalence of family
istory of coronary heart disease as compared with AA
ubjects (p  0.01). In general, AA and HS had a greater
requency for clustering 3 or more traditional cardiac risk
actors (p  0.0001).
The mean (standard deviation) score range and median
interquartile range) CAC score for the 14,812 asymptom-
tic individuals who were referred for screening was 146.2
63 (standard error of the mean) (score range 0 to 9,377)
nd 3 (0 to 78), respectively. Of the 14,812 individuals, 57%
ad a score of 10 or less. The prevalence of CAC scores of
1 to 100, 101 to 400, 401 to 999, and 1,000 was 20%,
4%, 6%, and 3%, respectively. Figure 1 demonstrates the
revalence of CAC categories across the ethnic groups. The
revalence of any CAC is 66%, 58%, 55%, and 55% for
HW, AA, HS, and AS, respectively (p  0.0001). As
ompared with NHW, all ethnic groups had lower odds of
aving any as well as increasing burden of CAC (p 
.0001).
ong-term prognosis by ethnicity. In the 10-year follow-
p, 505 all-cause deaths were observed. Overall survival was
6%, 93%, and 92% for AS, NHW, and HS as compared
Prevalence of Cardiac Risk Factors in 14,812Asymptomatic Individual Undergoing CAC Scre
Table 1 Prevalence of Cardiac Risk FactorsAsymptomatic Individuals Undergoi
Non-Hispanic
White
(n  11,776)
Age (yrs) 57 11
Family history of premature CAD (%) 60
Smoking (%) 9
Diabetes mellitus (%) 6
Hypertension (%) 28
Female gender (%) 44
Hyperlipidemia (%) 47
Number of risk factors
0 19
1–2 70
3 11
CAC  coronary artery calcium; CAD  coronary artery disease.ith 83% for AA, respectively (p  0.0001) (Fig. 2). Thenadjusted and risk-adjusted RRs for mortality across the
thnic groups are shown in Table 2. Multivariable analyses
evealed that AA race was an independent predictor of
eath (RR 2.9; 95% CI 1.9 to 4.6). The results persisted
ith additional adjustment for CAC scores (RR 3.0; 95%
I 1.9 to 4.7). After adjusting for age, gender, hypertension,
yperlipidemia, diabetes, and a family history of premature
oronary disease, HS and AS had a similar mortality risk as
ompared with NHW.
urvival by coronary calcium scores and ethnicity. The
verall unadjusted survival for the study population were
9.5%, 96.7%, 92.8%, 85%, and 72% for CAC scores of 10
r less, 11 to 100, 101 to 400, 401 to 999, and 1,000,
espectively (p  0.001). The multivariable adjusted RR
atios for mortality with increasing CAC scores in all ethnic
roups are shown in Table 3.
isk-adjusted survival by ethnicity. Using risk-stratified
ox proportional hazard survival analyses (Fig. 3), survival
or NHW ranged from 98% to 57% for CAC scores of 0 to
,812
C Screening
rican
erican
637)
Hispanic
(n  1,334)
Asian
(n  1,065) p Value
 11 53 11 55 12 0.0001
47 48 49 0.0001
14 11 8 0.002
18 17 12 0.0001
49 36 38 0.0001
57 52 52 0.0001
44 43 45 0.105
0.0001
20 21 23
58 63 64
22 16 13
Figure 1 Observed Frequency of CAC
Score Subsets by Ethnicity (n  14,812)
Prevalence of any coronary artery calcium (CAC) is 66%, 58%, 55%, and 55%
for non-Hispanic whites, African Americans, Hispanics, and Asians, respectively
(p  0.0001). As compared with non-Hispanic white, all ethnic groups had lower
odds of having any as well as an increasing burden of CAC (p  0.0001).ening
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Ethnic Differences in Prognosis of CAC September 4, 2007:953–600 to 1,000. In comparison, survival ranged from 97% to
0% in AA, 99% to 60% in HS, and 100% to 80% in AS.
sing a stratified Cox model, CAC remained predictive of
eath in a model controlling for age and risk factors in all
thnic subsets (p  0.0001). For subset multivariable
odels, CAC was predictive of death for NHW (p 
.0001), HS (p  0.0001), AA (p  0.0001), and for AS
p 0.002), respectively. Furthermore, in a stepwise model,
he CAC score was identified as the single greatest estima-
or of time to mortality for each ethnic subset.
A first-order interaction of CAC score with ethnicity was
tatistically significant in a model controlling for other
ardiac risk factors indicating differential effect of CAC on
ortality among the ethnic groups (p  0.0001). When
Multivariable Model on the Impact of Ethnicity iRisk-Adjusted an Calcium-Adjusted Cox Propor
Table 2 Multivariable Model on the ImpactRisk-Adjusted and Calcium-Adjusted
Relative Risk
Unadjusted model
Ethnicity
African American 2.54
Hispanic 1.13
Asian 0.82
Clinical risk adjustment*
Ethnicity
African American 2.93
Hispanic 1.67
Asian 0.88
Calcium risk adjustment†
Ethnicity
African American 2.97
Hispanic 1.58
Asian 0.85
Figure 2 Long-Term Survival in Ethnic Subsets (n  14,812)
Overall survival was 96%, 93%, and 92% for Asians, non-Hispanic whites, and
Hispanics as compared with 83% for African Americans, respectively (p 
0.0001). Among all ethnic groups, the lowest survival was observed in African
Americans (83%, p  0.0001).For each of the models, the reference group is non-Hispanic whites. *Clinical
reported in Table 1; †Calcium risk adjustment includes variables included in thomparing the predictive value of CAC scores in ethnic
inorities as compared with NHW, the RR ratio for CAC
1,000 is 9.0 for HS, 6.6 for AS, and 24 for AA (Fig. 4).
imilarly, higher RR ratios were noted for HS and AA with
AC scores 400.
redicted life expectancy by CAC scores in ethnic sub-
ets. The predicted changes in life expectancy for ethnic
ubsets by CAC score are shown in Figure 5. In each case
cross ethnic subsets, younger patients with CAC scores
100 to 1,000 had a reduced life expectancy. For 40-
ear-old NHW, life expectancy declined 2.0 to 5.9 years for
AC scores 100 to 1,000. Declines in life expec-
ancy were 2.3 to 0.9 years for 60- to 80-year-old NHW.
he declines in life expectancy were higher for ethnic
inority patients. That is, for 40-year-old subjects of
iverse ethnicity, declines in life expectancy ranged from 8.3
o 15.0 years for AA, 6.3 to 15.0 years for HS, and 2.6 to
2.0 years for AS.
iscussion
uring the past several decades, the U.S. population has
ecome increasingly ethnically diverse (4). To achieve a
eaningful impact from a preventive aspect on morbidity
nd mortality in the U.S., it is pragmatic to consider the
emographic diversity within the U.S. (1). Recent data from
merican Heart Association 2005 statistical fact sheets
ndicate a significant disparity from CVD mortality in
acial/ethnic groups (2).
The heterogeneity in CVD among ethnic subgroups may,
n part, be explained by known issues such as risk-factor
lustering (20), as well as underutilization of preventive
herapies (21,22) and acculturation and diminished access to
ealth care services (23,24). Some variability, however, may
e due to differing mechanisms of plaque formation, pro-
nicallyl H zards Models
nicity in Clinically
Proportional Hazards Models
Confidence
tervals Wald Chi-Square p Value
49 0.0001
49 0.0001
2–3.36 0.0001
5–1.52 0.40
5–1.21 0.31
367 0.0001
25 0.0001
6–4.62 0.0001
2–2.73 0.04
0–1.56 0.66
577 0.0001
24 0.0001
7–4.72 0.0001
2–2.71 0.096
7–1.54 0.60n Clitiona
of Eth
Cox
95%
In
1.9
0.8
0.5
1.8
1.0
0.5
1.8
0.9
0.4risk adjustment includes adjustment for all of the cardiac risk factors
e clinical risk-adjusted model plus the coronary artery calcium score.
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September 4, 2007:953–60 Ethnic Differences in Prognosis of CACression, rupture, and thrombosis, which are known precur-
ors of acute coronary syndromes and cardiac death (25).
he possible ethnic/racial differences in rates of CVD can
otentially be explored by identifying those with subclinical
therosclerosis and associated risk.
Coronary artery calcium is an established surrogate for
he overall magnitude of coronary atherosclerotic plaque
26). Since more than one-half of all first coronary heart
Figure 3 Cumulative Survival By CACS in Ethnic Subsets
(A to D) Using risk-stratified Cox proportional hazard survival analyses, the surviva
30% in African Americans, 99% to 60% in Hispanics, and 100% to 80% in Asians
ultivariable Model RRR for All-Cause Mortality by CAC Scores Ac
Table 3 Multivariable Model RRR for All-Cause Mortality by CA
CAC Score Overall Non-Hispanic White Afric
0–10 1 (reference) 1 (reference) 1 (ref
11–100 4.9 (3.6–6.8) 3.8 (2.6–5.6) 4.1 (1.6
100–400 10.5 (7.7–14.2) 6.9 (4.8–9.9) 12.3 (5.0
401–1,000 22.0 (16.0–30.3) 10.8 (7.4–15.7) 25.6 (9.9
1,000 45.3 (33.4–61.6) 24.8 (17.3–35.4) 39.5 (16
ll comparisons are p  0.0001 except where indicated.
CAC  coronary artery calcium; RRR  relative risk ratio.isease events are sudden cardiac deaths or acute myocardial
nfarctions in previously asymptomatic individuals, the em-
hasis has recently been focused on the identification of
igh-risk individuals with the potential inclusion of screen-
ng for CAC. It is now clearly established that increased
AC scores are consistent with increased cardiovascular
isk. Shaw et al. (6) reported on all-cause mortality in a large
ohort of 10,377 asymptomatic individuals followed for an
d from 98% to 57% in non-Hispanic whites, 97% to
onary artery calcium scores (CACS) of 0 to 10 to 1,000.
ng to Ethnicity
ores According to Ethnicity
erican Hispanic Asian
) 1 (reference) 1 (reference)
) p 0.004 4.2 (1.9–9.5) p 0.001 9.3 (1.3–66.2) p 0.026
) 3.7 (1.4–10.3) p 0.011 13.1 (2.8–61.9) p 0.001
) 19.1 (8.7–42.3) 17.6 (3.7–84.7)
4) 20.8 (7.5–57.7) 53.3 (11.3–251.2)l range
for corcordi
C Sc
an Am
erence
–10.8
–30.5
–66.3
.1–97.
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Ethnic Differences in Prognosis of CAC September 4, 2007:953–60verage of 5  3.5 years. At the end of follow-up, a total of
49 deaths were recorded. The CAC score was an indepen-
ent predictor of death (p  0.001) with risk increasing
roportionally to the baseline CAC scores. Greenland et al.
11) also demonstrated that high CAC scores can modify
redicted risk obtained from the Framingham risk index
lone, especially among patients in the intermediate risk
ategory in whom clinical decision making is most uncer-
ain. The results of the St. Francis Heart study, a prospec-
ive registry of 5,585 asymptomatic individuals, also dem-
Figure 4 RRRs (95% CIs) for CACS Subsets in HS,
AA, and AS Patients as Compared With NHW
The figure depicts the relative risk ratios (RRRs) of events for ethnic subsets
with increasing coronary artery calcium scores (CACS) as compared with non-
Hispanic whites (NHW). As compared with NHW, the relative risk ratio for CAC
1,000 is 9.0 for Hispanics (HS) (n  1,334), 6.6 for Asians (AS) (n 
1,065), and 24 for African Americans (AA) (n  637). CI  confidence interval.
Figure 5 Predicted Changes in Life Expectancy for Ethnic Subs
The figure depicts the change in life expectancy for ethnic subsets of this registry
artery calcium (CAC) scores 100, 400, and 1,000, respectively. The life expe
in life expectancy was highest among ethnic minorities with increasing levels of CAnstrated that higher CAC scores (100) were associated
ith RRs of 12 to 32 for CVD events achieving secondary
revention equivalent event rates 2% per year (8). Simi-
arly, Taylor et al. (9) showed CAC was associated with a
early 12-fold increased risk for incident coronary heart
isease controlling for the Framingham risk score in men
ge 40 to 50 years of age. In a recent study, Budoff et al. (10)
ollowed 25,253 asymptomatic individuals for a mean of 7
ears with nearly 21% followed for at least 10 years.
en-year survival (after adjustment for risk factors, includ-
ng age) was 99.4% for a CAC score of 0 and worsened to
7.8% for a score of 1,000 (p  0.0001). The addition of
AC to traditional risk factors increased the C-index
ignificantly (0.77 for age vs. 0.81 for the CAC score, p 
.0001). However, the results from these studies are largely
ased on NHW, with data on ethnic minorities missing.
Recently published studies have indicated that there are
thnic differences in the prevalence and extent of CAC
mong asymptomatic individuals. In a large asymptomatic
hysician-referred cohort of over 16,000 men and women
ge 45 to 84 years, Budoff et al. (12) reported that NHW
nd HS men had a significantly higher prevalence of CAC
hen compared with AA and AS men, despite a lower
revalence of hypertension, diabetes, and smoking (12).
hese differences persisted after controlling for standard
ardiac risk factors. The results of this study were similar to
hose reported in the MESA (Multi-Ethnic Study of
therosclerosis) study (13). After multivariable adjustment,
ompared with whites, the odds ratios for having CAC were
.78 (95% CI 0.74 to 0.82) in blacks, 0.85 (95% CI 0.79 to
y CAC Scores >100, >400, and >1,000, Respectively
se with significant-to-extensive atherosclerosis including those with coronary
y (on the vertical axis) is plotted by age of individual (horizontal axis). The decline
den.ets b
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September 4, 2007:953–60 Ethnic Differences in Prognosis of CAC.91) in Hispanics, and 0.92 (95% CI 0.85 to 0.99) in
hinese enrollees in the MESA study (p  0.001). Even
fter adjusting for risk factors, most studies have shown that
he prevalence of CAC is lower in ethnic minorities (12,13).
Consistent with prior reports, we found that ethnic
inorities largely had an increased clustering of risk factors
nd lower baseline CAC scores compared with NHW.
owever, our study is unique and adds to the literature by
escribing in detail for the first time the prognostic value of
AC in a large ethnically mixed cohort of asymptomatic
ndividuals. In our study, increasing CAC burden was
ssociated with a greater mortality in all ethnic/racial groups
ndependent of baseline risk factors, gender, and age.
However, the high mortality risk associated with CAC in
A seen in our study appears in conflict with a previous
eport (27). Doherty et al. (27) suggested that CAC may not
e as significant a prognostic marker in AA as in NHW. In
hat study, CAC determined by fluoroscopy was present in
0% of white subjects but only 35% of AA subjects (p 
.0001) (27). Nevertheless, after 70 months of follow-up,
ore AA than whites (24% vs. 15%; p  0.04) suffered a
VD event. African Americans were more likely to suffer an
vent even after adjusting for age, CAC score, and other
ardiac risk factors. As a result, the authors concluded:
Coronary calcium therefore does not carry the same patho-
iological significance in blacks that it does in whites” (27).
owever, it must be kept in mind that Doherty et al. (27)
id not report the relative prognosis with presence of CAC
n AA as compared with NHW. Also, the small sample size
f AA (n 93) in the study by Doherty et al. (27) precluded
ny significant inference on ethnic differences in outcome.
dditionally, CAC was not quantified, which might have
rovided improved risk stratification (27). By comparison,
ur study was sufficiently powered to detect differences
etween relatively large ethnic subsets from a well-
ontrolled, prospective registry. Our results imply that,
lthough AA have lower CAC scores, they display a sizeable
ncreased mortality risk with more extensive CAC burden.
Thus, it is possible that our results may help explain the
thnic paradox of CAC and survival observed in earlier
tudies. To understand our hypothesis, it is necessary to
onsider the epidemiologic principle defining prevalence,
hich is the product of incidence and the duration of
isease (28). As pointed out by Nieto and Blumenthal (28),
he apparent paradox is analogous to an earlier survey
howing that tuberculosis was less prevalent in American
lacks than in whites (29). Indeed, subsequent studies
emonstrated that tuberculosis incidence was much higher
n blacks, and their case fatality rate was also higher. As a
esult, earlier baseline findings were found to be simply a
roduct of the incidence-prevalence bias (29). Although we
eport that survival is shorter in ethnic minorities with
levated CAC scores, whether the incidence for CAC
evelopment is greater needs to be determined in future
rospective studies. rWhy do ethnic minority subsets, notably AA patients,
ith higher CAC scores have a greater mortality compared
ith NHW? Park et al. (30) have recently demonstrated
hat, in presence of higher CAC scores, higher levels of
nflammation are associated with poor prognosis. In our
tudy, we did not measure inflammatory markers, although
higher inflammatory burden in ethnic minorities, espe-
ially AA and HS, has been previously reported (31). Thus,
t may be that a smaller amount of calcium in the setting of
reater inflammation catapults CVD risk. Moreover, ethnic
inorities had more risk factors, which are frequently
ssociated with higher rates of inflammation. Also, substan-
ially higher comorbidities, levels of risk factors, and lower
ccess to health care treatment and preventive practices may
ontribute to shorter survival in the presence of advanced
nderlying subclinical atherosclerosis.
tudy limitations. Although the current article includes a
igorous analysis of the prognostic value of CAC, the
ajority of patients referred for calcium scanning had
ardiac risk factors and, as such, are not representative of the
eneral population. Residual confounding due to deficient
nd/or incomplete adjustment, including lack of socioeco-
omic status information, are important limitations. Large
rospective studies, such as the ongoing MESA study, may
e better equipped to take into account the baseline socio-
conomic status and health care access differences across
thnic groups and, as a result, provide clues to some of racial
isparity in mortality (32). However, the current results are
eneralizable to large patient cohorts that undergo CAC
maging across the U.S. under the direction of a referring
hysician.
In our study, CVD risk factors were self-reported. Hoff
t al. (33) noted good reliability of self-reported histories of
VD risk factors in referred individuals for EBT scanning.
ecause the CVD risk factors were self-reported, the potential
residual confounding” cannot be ruled out. However, in many
maging laboratories, patients are referred on the basis of a brief
istory with measured values frequently unavailable. The use of
elf-reported risk factors does represent standards for cardiac
esting that are commonly applied in cardiovascular medicine.
hus, we believe that our analysis is a close representation of
aily practice. The study populations were fairly homogeneous
n the sense that they were highly motivated to assess their
VD risk and were able to afford the expense associated with
he EBT scan. These findings raise the possibility that such
hysician-referred populations differ from the general popula-
ion in their use of screening procedures and other preventive
easures.
Our models do not include the cause of death and, as
uch, our models may be based on mortality unrelated to
therosclerotic disease. However, all-cause mortality is an
ppropriate end point to follow, since when one accounts for
oth cardiac and systemic forms of the disease, nearly
hree-fourths of all deaths have been related to atheroscle-
osis (5). Furthermore, this end point is unaffected by the
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onclusions
here is currently a paucity of evidence as to the prognostic
alue of many commonly performed cardiac diagnostic tests
n ethnic minority patients. Our results provide evidence
hat CAC screening provides prognostic information based
pon the extent and severity of subclinical atherosclerosis
mong all ethnic subgroups. A greater intensity of treatment
n the presence of CAC may reduce the excess morbidity
nd mortality for ethnic minority patients. Unfolding this
vidence should aid in developing management strategies
ptimized for ethnically diverse patient populations. Finally,
ndings from our study provide support for the develop-
ent of ethnic-specific guidelines and more aggressive
opulation-specific screening and educational programs fo-
used on ethnic minorities.
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